Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock
HOUSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery...